Healthcare & Clinical Calculators
Vienna CATS Cancer Thrombosis Research: Score Arithmetic
Explore the 2010 Vienna CATS biomarker research model and test its point arithmetic with fictional inputs.
A research cohort, not a personal treatment plan
In a 2010 prospective study of 819 people with newly diagnosed cancer or progression after remission, Ay and colleagues expanded a clinical VTE score with D-dimer and soluble P-selectin. In that study, 61 participants experienced VTE during follow-up; the authors reported six-month cumulative probabilities for different score groups.
For example, the original cohort had an estimated 35.0% six-month cumulative VTE probability for scores of 5 or more, a group of only 30 participants. This is a cohort estimate, not a guaranteed individual probability. A later prospective comparison found that performance varied across cohorts and noted the difficulty of obtaining the biomarker measurements.
| 2010 study group | Participants | Reported 6-month cumulative VTE probability |
|---|---|---|
| Score 0 | 200 | 1.0% |
| Score 3 | 130 | 10.3% |
| Score ≥5 | 30 | 35.0% |
Practice the historical point calculation
The original expanded model assigned one point for D-dimer at least 1.44 µg/mL and one for soluble P-selectin at least 53.1 ng/mL, in addition to a separately determined clinical base score. The example below checks fictional numerical inputs and adds those points; it does not validate the underlying clinical base, laboratory assay or a patient’s risk.
Assay methods and units matter, and the 2010 study’s cutoff values should not be transferred blindly to another laboratory. Decisions about prevention require clinical judgment and assessment of bleeding risk; consult current hematology guidance rather than using this worksheet to select treatment.
=IF(COUNT(B2:B4)<>3,"Enter all three numeric values",IF(OR(B2<0,B2>6,MOD(B2,1)<>0,B3<0,B4<0),"Check base score and biomarker values",B2+IF(B3>=1.44,1,0)+IF(B4>=53.1,1,0)))Try the example
Use the original values or change them to test your understanding.